News
Media
Peer ExchangeCase-Based Psych PerspectivesClinical Case CollectiveInsightsPeers & PerspectivesSlideshowsVideos
Conferences
Conference CoverageConference Listing
Publication
Psychiatric Times
More
Job Board
CME/CE
Partners
Editorial
Resources
Between the LinesExpert PerspectivesClinical ConsultClinical ScalesInteractive ToolsLive EventsPartner PerspectivesQ&AQuizzesSeriesSpecial ReportsSponsored

Subscribe

  • News
  • Media
  • Conferences
  • Publication
  • Job Board
  • CME/CE
  • Partners
  • Editorial
  • Resources
  • Subscribe
  • ADHD
  • Addiction & Substance Use
    • Gambling
    • Opioid Related Disorders
    • Alcohol Abuse
    • Amphetamine Related Disorders
    • Substance Use Disorder
  • Alzheimer Disease
  • Anxiety & Stress Disorders
    • Disaster Psychiatry
    • Panic Disorder
    • Trauma And Violence
    • Traumatic Stress Disorders
  • Bipolar Disorder
    • Mania
  • COVID-19
  • Cannabis
  • Case Discussions
  • Child & Adolescent Psychiatry
  • Climate Change
  • Comorbidity
  • Compulsive Disorders
  • Cultural Psychiatry
  • Digital Therapeutics
  • Diversity, Equity, Inclusion
  • Drug Watch
  • Eating Disorders
  • Emergency Psychiatry
  • Ethics
  • Forensic Psychiatry
    • Munchausen Syndrome
    • Sexual Offenses
  • Geriatric Psychiatry
  • Integrative Psychiatry
  • Major Depressive Disorder
  • Media & Psychiatry
  • Mental Health Awareness Month
  • Mood Disorders
  • Neuropsychiatry
    • Cognitive Disorders
    • Dementia
    • Autism
  • PTSD
  • Personality Disorders
    • Compulsive Personality Disorder
    • Dependent Personality Disorder
    • Dissociative Identity Disorder
    • Histrionic Personality Disorder
    • Schizoid Personality Disorder
    • Antisocial Personality Disorder
    • Borderline Personality
  • Postpartum Depression
  • Psychedelics
  • Psychopharmacology
  • Psychosomatics
    • Delirium
    • Metabolic Disorders
    • Somatoform Disorder
  • Psychotherapy
    • Cognitive Behavioral Therapy
  • Schizophrenia/Psychosis
    • Paranoid Schizophrenia
    • Psychotic Affective Disorders
    • Schizoaffective
    • Schizophrenia Psychotic Features
    • Schizotypal Personality Disorder
    • Catatonic Schizophrenia
  • Sleep Disorders
    • Nocturnal Paroxysmal Dystonia
    • Sleep Deprivation
    • Sleep Wake Transition
    • Circadian Rhythm Sleep Disorders
  • Special Populations
    • Pervasive Developmental Disorder
    • Gender Issues
    • Military Mental Health
  • Sports Psychiatry
  • Suicide
  • Tardive Dyskinesia
  • Technology & Psychiatry
  • Transcranial Magnetic Stimulation
Spotlight -
Long-Acting Injectable Therapy in the Management of Adult Patients with Schizophrenia|
Major Depressive Disorder
Advertisement
|Slideshows|May 28, 2020

Dosing Secrets for the Top Mood Stabilizers

Author(s)Chris Aiken, MD

These mood stabilizers cover a lot of ground, but it is important to know how to use them.

Advertisement

Newsletter

Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.

Subscribe Now!
Advertisement

Related Content

Advertisement
bipolar disorder

Through the Peaks and Valleys: Assessing and Addressing Suicide Risk in Bipolar Disorder

ByAndrew Nguyen, MD, MSc,Ayal Schaffer, MD, FRCPC
November 26th 2025
bipolar

Lamotrigine: An Update on Its Role in Bipolar Disorder

ByDavid N. Osser, MD
November 14th 2025
blood test

Patent Issued for Rapid Blood Tests to Differentiate Schizophrenia and Bipolar Disorder

ByLeah Kuntz
October 23rd 2025
bipolar disorder

FDA Approves Uzedy Once-Monthly Extended Release Injectable Suspension for Bipolar I Disorder

ByLeah Kuntz
October 16th 2025
bipolar disorder

The Use of Aripiprazole for Bipolar Disorder

ByDavid N. Osser, MD
October 15th 2025
Advertisement
Advertisement

Trending on Psychiatric Times

1

The Hybrid Model: Humans & Chatbots Working Together

2

Interrelation of Hormones and Adult ADHD

3

The Truth About Insomnia and Melatonin: Natural Does Not Always Mean Harmless

4

Through the Peaks and Valleys: Assessing and Addressing Suicide Risk in Bipolar Disorder

5

New Drug Application Submitted for Centanafidine for Treatment of ADHD

  • About
  • Advertise
  • Contact Us
  • Editorial
  • Terms and Conditions
  • Privacy Policy
  • Do Not Sell My Personal Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us